3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
11
Cancer Pain
11
Pain
9
Pain, Postoperative
5
Agnosia
5
Colorectal Neoplasms
3
Colonic Neoplasms
3
Neoplastic Cells, Circulating
2
Neoplasm Metastasis
2
Mucositis
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Inflammation
2
Head and Neck Neoplasms
2
Chronic Pain
2
Breakthrough Pain
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Signs and Symptoms
1
Sezary Syndrome
1
Reperfusion Injury
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Lidocaine
4
Oxycodone
2
Capsaicin
2
ziconotide
1
nabiximols
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Transcranial Magnetic Stimulation
1
Thalidomide
1
Telmisartan
1
Tapentadol
1
Surveys and Questionnaires
1
Sodium Chloride
1
Pregabalin
1
Plastic Surgery Procedures
1
Paclitaxel
1
Oxaliplatin
1
Morphine
1
Methadone
1
Manipulation, Osteopathic
1
Lidoderm
1
Ketamine
1
KRN 5500
1
Hypnosis
1
Hydromorphone
1
Geritol
1
Gabapentin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neuralgia
×
Morphine
×
Clear all
NCT01946555
2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
150 enrolled